OBBI is dedicated to facilitate, accelerate and optimize the bioproduction of organoids and extracellular vesicles for the biotech and pharmaceutical industries, as well as academics focusing on maturation projects and pre-industrial development, with a common objective to bring innovative solutions for the treatments of the future.
At OBBI, we are proud to be your trusted and agile partner in Biotechnological Innovation.
OBBI develops disease-specific and physiologically normal organoid models, as well as tumoroids and spheroids. We also design and optimize scalable bioproduction processes to ensure reproducibility, quality, and industrial transferability.
OBBI produces EVs from various cell sources, including mesenchymal stromal cells and organoids. We develop and standardize bioproduction processes to ensure high yield, purity, and compatibility with industrial and clinical applications.
Our specialized QC Bioprod facility ensures rigorous monitoring and validation at every step, guaranteeing that each batch delivers outstanding performance, consistency, and scalability. This commitment to excellence aligns our production with both cutting-edge scientific standards and regulatory requirements.
Our team provides comprehensive support – spanning early project design, process optimization, scale-up, and regulatory preparation – to ensure every initiative is scientifically sound, economically viable, and aligned with industry standards.
At OBBI, we harness the potential of breakthrough platforms specilized in organoids and extracellular vesicles bioproduction to drive innovation in drug discovery, regenerative medicine, and advanced diagnostics. Through scalable bioproduction and rigorous quality standards, we bridge academic research and industrial needs, helping transform scientific discoveries into clinical and commercial solutions.
At OBBI, our vision, mission, and values are the cornerstone of our commitment to help driving innovation in the bioproduction of organoids and extracellular vesicules. We partner with academics, biotech and pharmaceutical companies to bring ground breaking solutions, ensuring that together we can advance in developing new biotherapies, novel models for drug development and screening, new drug delivery systems, biomarkers for diagnosis, prognosis, monitoring in personalized and regenerative medicine
We aim to accelerate and lead the way in the standardization, high-yield production, and scaling of organoids and EVs as indispensable tools in the future of medical and research applications.
Our mission is to accelerate and drive advancements in organoid and EV technologies with our partners. By leveraging cutting-edge research and state-of-the-art facilities, we provide the tools and expertise necessary to develop and scale up these pioneering technologies, facilitating the creation of effective and personalized biotherapies and bioproductions. Our team works to foster a collaborative and dynamic environment where innovative ideas thrive, ensuring that our partners receive a support and expertise of excellence in their ongoing or under-development projects.
Innovation, expertise and excellence associated with ethics and integrity are the core values that guide us. We are dedicated to delivering cutting-edge bioproduction solutions with the highest standards of quality and reliability.
